Xylocaine Injection

Xylocaine Injection

lidocaine

Manufacturer:

Aspen Pharmacare Asia

Distributor:

Cordial Trading
/
Primal
Concise Prescribing Info
Contents
Lidocaine HCl
Indications/Uses
Production of local or regional anaesth by infiltration techniques; IV regional anaesth, by peripheral nerve block techniques eg, intercostal blocks; major plexus blocks eg, brachial plexus blocks & by epidural & subarachnoid blocks.
Dosage/Direction for Use
The lowest dosage that results in effective anaesth should be used. Adult Infiltration 20 mL of 1% inj or 10 mL of 2% inj. Paravertebral nerve block 3-5 mL of 1% inj. Pudendal block 10 mL of 1% inj on each side. Paracervical block 10 mL of 1% inj. Stellate ganglion block Cervical: 5 mL of 1% inj. Lumbar: 10 mL of 1% inj. Epidural anaesth Thoracic: 10-20 mL of 1% inj. Lumbar: 5-10 mL of 2% inj. Lumbar or caudal epidural analgesia 10-20 mL of 1% inj.
Contraindications
Known hypersensitivity to local anaesth of the amide-type, or methyl parahydroxybenzoate (MDV only). Not to be used for epidural or spinal anaesth in patients w/ uncorrected hypotension or w/ coagulation disorders or receiving anticoagulation treatment. Not to be used when there is inflammation &/or sepsis in the region of proposed inj or in the presence of septicaemia.
Special Precautions
Inj should always be made slowly w/ frequent aspirations. Reports of chondrolysis. Should not be used for post-op intra-articular continuous infusion. Epidural or spinal haematoma. Debilitated, elderly or acutely ill patients. Patients w/ epilepsy, impaired cardiac conduction, bradycardia, severe shock or digitalis intoxication; impaired CV function; preexisting abnormal neurological pathology eg, myasthenia gravis. Serious diseases of the CNS or of the spinal cord eg, meningitis, spinal fluid block, cranial or spinal haemorrhage, tumours, poliomyelitis, syphilis, tuberculosis or metastatic lesions of the spinal cord. Hepatic &/or renal impairment, genetic predisposition to malignant hyperthermia. Paracervical blocks during pregnancy. Porphyric patients. Avoid intravascular inj. May temporarily impair locomotion & coordination.
Adverse Reactions
CNS reactions, either excitatory or depressant. CV reactions, mainly depressant. Maternal hypotension. Rarely allergic reactions.
Drug Interactions
Antiarrhythmic drugs. Reduced clearance w/ amiodarone. Reduced metabolism w/ β-blockers. Reduced clearance w/ cimetidine. Enhanced metabolism w/ anticonvulsive agents eg, phenobarb, primidone, carbamazepine. Decreased minimum effective conc of inhalational anaesth. Excessive neuromuscular blockade w/ skeletal muscle relaxants. Structurally-related local anaesth.
MIMS Class
Anaesthetics - Local & General
ATC Classification
N01BB02 - lidocaine ; Belongs to the class of amides. Used as local anesthetics.
Presentation/Packing
Form
Xylocaine Injection inj 1 %
Packing/Price
5 mL x 50 × 1's
Form
Xylocaine Injection inj 2 %
Packing/Price
5 mL x 50 × 1's
Exclusive offer for doctors
Register for a MIMS account and receive free medical publications worth $768 a year.
Already a member? Sign in
Exclusive offer for doctors
Register for a MIMS account and receive free medical publications worth $768 a year.
Already a member? Sign in